Editorial commentary: turning the tide on HIV in women and children: preventing breast-milk HIV transmission while increasing maternal life expectancy.
Becquet, Renaud; Dabis, François.
Clin Infect Dis
; 56(1): 140-2, 2013 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-22997213
Pooled individual data analysis of 5 randomized trials of infant nevirapine prophylaxis to prevent breast-milk HIV-1 transmission.
Clonal amplification and maternal-infant transmission of nevirapine-resistant HIV-1 variants in breast milk following single-dose nevirapine prophylaxis.
Valacyclovir suppressive therapy reduces plasma and breast milk HIV-1 RNA levels during pregnancy and postpartum: a randomized trial.
Prevention of TB using rifampicin plus isoniazid reduces nevirapine concentrations in HIV-exposed infants.
Optimisation of antiretroviral therapy in HIV-infected children under 3 years of age.
Effectiveness of antiretroviral therapy in HIV-infected children under 2 years of age.
Effects of short-course zidovudine on the selection of nevirapine-resistant HIV-1 in women taking single-dose nevirapine.
Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission.
Prevention of perinatal HIV I transmission by protease inhibitor based triple drug antiretroviral therapy versus nevirapine as single dose at the time of delivery.
Antiretroviral interventions for preventing breast milk transmission of HIV.